Philip Schmalz is a native of New Orleans, Louisiana. He completed his undergraduate studies at Washington and Lee University and the College of Charleston, where he served as a skipper on their nationally renowned sailing team. After graduation, Dr. Schmalz was hired by the Massachusetts Institute of Technology's Broad Institute in Cambridge, MA in the Technology Development division working to scale up new genomic sequencing platforms and processes. He returned to New Orleans to complete his medical studies at Tulane University, but was promptly lured back to the lab as a Howard Hughes Medical Institute Research Scholar at the National Institutes of Health. While at HHMI-NIH under the guidance of Dr. John K. Park, he worked to develop new immunotherapeutics for the treatment of malignant gliomas as well as novel techniques in murine glioma models. His neurosurgical interests include cerebrovascular and skull base surgery, neuro-oncology, specifically the immunology and immunotherapy of malignant brain tumors, as well as functional neurosurgery.